According to the ICH guideline Q1A(R2) adopted by the FDA and EMA, the goal of stability testing is to demonstrate “how the quality of a drug substance or drug product varies with […]

Recently, there has been much excitement and activity here at Pacific BioLabs regarding the future dedicated stability suite.  This long awaited project, which should be up and running in about […]